Molecular basis for enhanced activity of posaconazole against Absidia corymbifera and Rhizopus oryzae
- PMID: 16966400
- PMCID: PMC1635193
- DOI: 10.1128/AAC.00747-06
Molecular basis for enhanced activity of posaconazole against Absidia corymbifera and Rhizopus oryzae
Abstract
Posaconazole and itraconazole were more potent inhibitors of ergosterol synthesis, in both intact cells and cell extracts from Absidia corymbifera and Rhizopus oryzae, than voriconazole and fluconazole. Similarly, expression of CYP51 from R. oryzae in Saccharomyces cerevisiae significantly increased resistance to fluconazole and voriconazole but not to posaconazole and itraconazole.
Figures

Similar articles
-
Activity of posaconazole in treatment of experimental disseminated zygomycosis.Antimicrob Agents Chemother. 2003 Nov;47(11):3647-50. doi: 10.1128/AAC.47.11.3647-3650.2003. Antimicrob Agents Chemother. 2003. PMID: 14576138 Free PMC article.
-
Interaction of amphotericin B lipid formulations and triazoles with human polymorphonuclear leucocytes for antifungal activity against Zygomycetes.Mycoses. 2008 Mar;51(2):147-54. doi: 10.1111/j.1439-0507.2007.01457.x. Mycoses. 2008. PMID: 18254752
-
Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae.Antimicrob Agents Chemother. 2015 Dec;59(12):7830-2. doi: 10.1128/AAC.01583-15. Epub 2015 Sep 21. Antimicrob Agents Chemother. 2015. PMID: 26392499 Free PMC article.
-
New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.Expert Rev Anti Infect Ther. 2009 Oct;7(8):981-98. doi: 10.1586/eri.09.67. Expert Rev Anti Infect Ther. 2009. PMID: 19803707 Review.
-
Cytochrome P450 lanosterol 14α-demethylase (CYP51): insights from molecular genetic analysis of the ERG11 gene in Saccharomyces cerevisiae.J Steroid Biochem Mol Biol. 1992 Dec;43(8):1107-16. doi: 10.1016/0960-0760(92)90339-K. J Steroid Biochem Mol Biol. 1992. PMID: 22217856 Review.
Cited by
-
Whole genome analysis of Rhizopus species causing rhino-cerebral mucormycosis during the COVID-19 pandemic.Front Cell Infect Microbiol. 2023 Oct 31;13:1251456. doi: 10.3389/fcimb.2023.1251456. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 38029246 Free PMC article.
-
Structural characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei bound to the antifungal drugs posaconazole and fluconazole.PLoS Negl Trop Dis. 2010 Apr 6;4(4):e651. doi: 10.1371/journal.pntd.0000651. PLoS Negl Trop Dis. 2010. PMID: 20386598 Free PMC article.
-
Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis.Antimicrob Agents Chemother. 2014 Nov;58(11):6767-72. doi: 10.1128/AAC.03569-14. Epub 2014 Sep 2. Antimicrob Agents Chemother. 2014. PMID: 25182639 Free PMC article.
-
Intrinsic short-tailed azole resistance in mucormycetes is due to an evolutionary conserved aminoacid substitution of the lanosterol 14α-demethylase.Sci Rep. 2017 Nov 21;7(1):15898. doi: 10.1038/s41598-017-16123-9. Sci Rep. 2017. PMID: 29162893 Free PMC article.
-
In vitro Activity of Isavuconazole and Comparators Against Clinical Isolates of Molds from a Multicenter Study in China.Infect Drug Resist. 2022 Apr 22;15:2101-2113. doi: 10.2147/IDR.S360191. eCollection 2022. Infect Drug Resist. 2022. PMID: 35498631 Free PMC article.
References
-
- Ballard, S. A., S. L. Kelly, S. W. Ellis, and P. F. Troke. 1990. Interaction of microsomal cytochrome P-450 isolated from Aspergillus fumigatus with fluconazole and itraconazole. J. Med. Vet. Mycol. 28:327-334. - PubMed
-
- Calabrese, D., J. Bille, and D. Sanglard. 2000. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. Microbiology 146:2743-2754. - PubMed
-
- Clinical and Laboratory Standards Institute. 2002. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Approved standard M38-A. National Committee for Laboratory Standards, Wayne, Pa.
-
- Goldman, G. H., M. E. da Silva Ferreiraqq, Edos Reis Marques, M. Savoldi, D. Perlin, S. Park, P. C. Godoy Martinez, M. H. Goldman, and A. L. Colombo. 2004. Evaluation of fluconazole resistance mechanisms in Candida albicans clinical isolates from HIV-infected patients in Brazil. Diagn. Microbiol. Infect. Dis. 501:25-32. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases